Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Blasczyk

Showing results (61-70 of 210) with videos related to

Pageof 21
Sort By:
Immunogenetics|August 22, 2018
The polymorphism at residue 156 determines the HLA-B*35 restricted peptide repertoire during HCMV infectionWiebke C Abels, Trishna Manandhar, Heike Kunze-Schumacher, et al.
African Journal of Laboratory Medicine|September 8, 2017
Red cell allo- and autoimmunisation in transfused sickle cell and cancer patients in Kenyatta National Hospital, Nairobi, KenyaCaroline Mangare, Amos Mbugua, Peter Maturi, et al.
Transfusion|April 19, 2002
A weak blood group A phenotype caused by a new mutation at the ABO locusAxel Seltsam, Michael Hallensleben, Britta Eiz-Vesper, et al.
Stem Cell Research & Therapy|August 23, 2015
Molecular and cellular characteristics of human and non-human primate multipotent stromal cells from the amnion and bone marrow during long term cultureOlena Pogozhykh, Denys Pogozhykh, Anna-Lena Neehus, et al.
Transfusion|April 12, 2005
A dose-response analysis of lenograstim plus dexamethasone for neutrophil mobilization and collectionHans-Gert Heuft, Lilia Goudeva, Nicole Pulver, et al.
Immunogenetics|April 1, 2018
HLA-G peptide preferences change in transformed cells: impact on the binding motifAlexander A Celik, Gwendolin S Simper, Wiebke Hiemisch, et al.
Transfusion|August 1, 2012
Semaphorin 7A protein variants differentially regulate T-cell activityChristiane Gras, Britta Eiz-Vesper, Axel Seltsam, et al.
Immunogenetics|February 13, 2007
Amino acid 95 causes strong alteration of peptide position Pomega in HLA-B*41 variantsChristina Bade-Doeding, David S DeLuca, Axel Seltsam, et al.
Immunogenetics|April 26, 2019
Correction to: HLA-F*01:01 presents peptides with N-terminal flexibility and a preferred length of 16 residuesGia-Gia T Hò, Funmilola J Heinen, Trevor Huyton, et al.
International Journal of Molecular Sciences|November 14, 2019
HLA-F Allele-Specific Peptide Restriction Represents an Exceptional Proteomic FootprintGia-Gia T Hò, Funmilola J Heinen, Rainer Blasczyk, et al.
Pageof 21

Showing results (61-70 of 210) with videos related to

Sort By:
Pageof 21
Immunogenetics|August 22, 2018
The polymorphism at residue 156 determines the HLA-B*35 restricted peptide repertoire during HCMV infectionWiebke C Abels, Trishna Manandhar, Heike Kunze-Schumacher, et al.
African Journal of Laboratory Medicine|September 8, 2017
Red cell allo- and autoimmunisation in transfused sickle cell and cancer patients in Kenyatta National Hospital, Nairobi, KenyaCaroline Mangare, Amos Mbugua, Peter Maturi, et al.
Transfusion|April 19, 2002
A weak blood group A phenotype caused by a new mutation at the ABO locusAxel Seltsam, Michael Hallensleben, Britta Eiz-Vesper, et al.
Stem Cell Research & Therapy|August 23, 2015
Molecular and cellular characteristics of human and non-human primate multipotent stromal cells from the amnion and bone marrow during long term cultureOlena Pogozhykh, Denys Pogozhykh, Anna-Lena Neehus, et al.
Transfusion|April 12, 2005
A dose-response analysis of lenograstim plus dexamethasone for neutrophil mobilization and collectionHans-Gert Heuft, Lilia Goudeva, Nicole Pulver, et al.
Immunogenetics|April 1, 2018
HLA-G peptide preferences change in transformed cells: impact on the binding motifAlexander A Celik, Gwendolin S Simper, Wiebke Hiemisch, et al.
Transfusion|August 1, 2012
Semaphorin 7A protein variants differentially regulate T-cell activityChristiane Gras, Britta Eiz-Vesper, Axel Seltsam, et al.
Immunogenetics|February 13, 2007
Amino acid 95 causes strong alteration of peptide position Pomega in HLA-B*41 variantsChristina Bade-Doeding, David S DeLuca, Axel Seltsam, et al.
Immunogenetics|April 26, 2019
Correction to: HLA-F*01:01 presents peptides with N-terminal flexibility and a preferred length of 16 residuesGia-Gia T Hò, Funmilola J Heinen, Trevor Huyton, et al.
International Journal of Molecular Sciences|November 14, 2019
HLA-F Allele-Specific Peptide Restriction Represents an Exceptional Proteomic FootprintGia-Gia T Hò, Funmilola J Heinen, Rainer Blasczyk, et al.
Pageof 21